Related references
Note: Only part of the references are listed.Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
Kholoud F. Aliter et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism as Bridge to Therapy
Lukasz Kmiec et al.
ASAIO JOURNAL (2020)
Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation A Worldwide Survey
Alessandro Protti et al.
ANESTHESIOLOGY (2020)
Incidence of early intra-cranial bleeding and ischaemia in adult veno-arterial extracorporeal membrane oxygenation and extracorporeal cardiopulmonary resuscitation patients: a retrospective analysis of risk factors
Maximilian Valentin Malfertheiner et al.
PERFUSION-UK (2020)
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
Ryan P. Barbaro et al.
LANCET (2020)
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies
Alessandro Di Minno et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
Evaluation of a heparin monitoring protocol for extracorporeal membrane oxygenation and review of the literature
Ellen Colman et al.
JOURNAL OF THORACIC DISEASE (2019)
Incidence and Risk Factors for Cannula-Related Venous Thrombosis After Venovenous Extracorporeal Membrane Oxygenation in Adult Patients With Acute Respiratory Failure
Christoph Fisser et al.
CRITICAL CARE MEDICINE (2019)
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study
Antoine Kimmoun et al.
INTENSIVE CARE MEDICINE (2018)
Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis
Eric Sy et al.
JOURNAL OF CRITICAL CARE (2017)
Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
Mario Menk et al.
ANNALS OF INTENSIVE CARE (2017)
Time in Therapeutic Range for Left Ventricular Assist Device Patients Anticoagulated With Warfarin: A Correlation to Clinical Outcomes
Laura C. Halder et al.
ASAIO JOURNAL (2017)
Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study
Alexander Fletcher Sandersjoo et al.
JOURNAL OF INTENSIVE CARE (2017)
Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis
Michael Mazzeffi et al.
ANNALS OF THORACIC SURGERY (2016)
Extracorporeal membrane oxygenation: evolving epidemiology and mortality
Christian Karagiannidis et al.
INTENSIVE CARE MEDICINE (2016)
Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure A Systematic Review
Michael C. Sklar et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Comparison of Coagulation Parameters, Anticoagulation, and Need for Transfusion in Patients on Interventional Lung Assist or Veno-Venous Extracorporeal Membrane Oxygenation
Christian Weingart et al.
ARTIFICIAL ORGANS (2015)
Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin
Megan A. Coughlin et al.
ASAIO JOURNAL (2015)
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis
Se-Chan Kim et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2015)
Heparin-Induced Thrombocytopenia
Naomi B. Klarenbeek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange - Retrospective Analysis of 265 Cases
Matthias Lubnow et al.
PLOS ONE (2014)
Apparent Argatroban Resistance in a Patient with Elevated Factor VIII Levels
Dina M. Kennedy et al.
ANNALS OF PHARMACOTHERAPY (2013)
Alternative Monitoring of Argatroban Using Plasma-Diluted Thrombin Time
Matthew A. Wanat et al.
ANNALS OF PHARMACOTHERAPY (2013)
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - A European Perspective
Adriano Alatri et al.
THROMBOSIS RESEARCH (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Monitoring direct thrombin inhibitors with a plasma diluted thrombin time
Jason E. Love et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Argatroban in extracorporeal membrane oxygenation
Martin Beiderlinden et al.
ARTIFICIAL ORGANS (2007)
Heparin-induced thrombocytopenia in intensive care patients
Kathleen Selleng et al.
CRITICAL CARE MEDICINE (2007)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits
G Young et al.
PERFUSION-UK (2004)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
BE Lewis et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)
FB Taylor et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Share Paper
